Fig. 6From: Quality assessment and Q-markers discovery of Tongsaimai tablet by integrating serum pharmacochemistry and network pharmacology for anti-atherosclerosis benefitHPLC chromatograms of negative control (A), mixed reference substance (B), and TSMT samples (C). Peak 1–5 represented Liquiritin, Ferulic acid, Senkyunolide I, Luteolin, and Glycyrrhizic acid, respectivelyBack to article page